October 26, 2022

Press Release: NCI-MATCH cancer trial finds a promising signal for the AKT inhibitor ipatasertib

October 21, 2022

Press Release: Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting to assess the stage of disease more accurately using standard CT scans

October 20, 2022

Press Release: ECOG-ACRIN taps the University of Pennsylvaniaโ€™s Selina Luger to lead its Leukemia Committee

September 27, 2022

Media Advisory: Journal of Clinical Oncology publishes outcomes from the practice-changing DREAMseq trial in patients with advanced melanoma

September 8, 2022

Press Release: ECOG-ACRIN completes the first randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

July 14, 2022

Media Advisory: Blood publishes long-term outcomes of patients with CLL in the practice-changing E1912 trial

May 27, 2022

Press Release: ECOG-ACRIN research highlights at ASCO 2022

May 17, 2022

Media Advisory: ECOG-ACRIN data at ASCO will showcase the Groupโ€™s robust research portfolio

March 25, 2022

Press Release: Enrollment in TMIST breast cancer screening trial surpasses halfway mark; recruitment of women from diverse backgrounds is key to success

ECOG-ACRIN Cancer Research Group